Oracle Shares Plunge 11% After Q2 Revenues Miss: Should You Hold?

Oracle reported Q2 fiscal 2026 revenue of $16.1 billion (+14% Y/Y in USD, +13% cc), missing consensus by 0.55%, while cloud revenue accelerated to $8.0 billion (+34% USD) and now comprises half of sales; cloud infrastructure rose 66% cc (GPU-related cloud +177%) even as legacy software revenue fell ~3% USD. Remaining performance obligations jumped to $523 billion (+438% Y/Y) driven by large deals with Meta and NVIDIA, with short‑term RPO up 40% Y/Y and management flagging roughly $4 billion of monetizable backlog for fiscal 2027. However, free cash flow turned negative $10 billion after $12 billion of quarterly CapEx and Oracle raised full‑year CapEx guidance to about $50 billion, a dynamic that, despite EPS uplift from a $2.7 billion Ampere-related gain and strong cloud growth guidance, pressures near‑term cash generation. Given elevated CapEx, intense cloud competition and a premium valuation (forward P/S ~8.4x), Zacks views the stock as a hold awaiting clearer execution and cash‑flow improvement.

Analysis

Oracle reported fiscal Q2 revenue of $16.1 billion, up 14% year-over-year in USD (13% cc) but missing consensus by 0.55%, while cloud revenue accelerated to $8.0 billion (+34% USD, +33% cc) and now represents 50% of total sales; cloud infrastructure reached $4.1 billion (+66% cc) with GPU-related cloud revenues up 177%, and cloud applications were $3.9 billion (+11%). Software/legacy revenues weakened, declining to $5.9 billion (-3% USD, -5% cc), highlighting a shifting revenue mix as multicloud database sales exploded (817% growth) and large deals with Meta and NVIDIA drove remaining performance obligations (RPO) to $523 billion, up 438% year-over-year and $68 billion sequentially. Short-term monetization appears promising: RPO expected to be recognized within 12 months grew 40% year-over-year and management expects roughly $4 billion of additional revenue available to monetize in fiscal 2027, with Q3 cloud growth guided at 37%–41% cc and total revenue growth guided at 16%–18% cc. Near-term financial risks center on cash flow and valuation: free cash flow was negative $10 billion after $12 billion of quarterly CapEx and management raised full-year CapEx guidance by $15 billion to ~ $50 billion; non-GAAP EPS benefited from a $2.7 billion pre-tax Ampere sale gain, and the stock trades at a premium (forward P/S ~8.4x versus industry 7.6x), supporting a cautious hold stance until execution and cash generation improve.

Key Decisions for Investors

• Existing holders should maintain positions near term but monitor free cash flow, quarterly operating cash flow, and the pace of CapEx deployment closely; trim exposure if negative FCF persists or CapEx guidance is raised again
• Prospective buyers should defer sizable new positions until Oracle demonstrates FCF turn‑positive or a clear path to monetize the large RPO backlog (watch for the company to realize the cited ~$4 billion for fiscal 2027), consider staggered entries to manage timing risk
• Track operational indicators including RPO recognized within 12 months, conversion of large deals (Meta, NVIDIA), sustained GPU-related cloud revenue growth, and actuals versus the Q3 cloud revenue guidance as primary catalysts that would justify re-rating
• Consider short-duration downside protection (puts or collars) against continued cash-flow pressure given the elevated CapEx program and stretched valuation if seeking to maintain exposure through the execution period